Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 72-78

  Wallin, Annika ^a   Sue Chu, Malcolm ^b   Bjermer, Leif ^c   Ward, Jonathan ^d   Sandström, Thomas ^a   Lindberg, Anne ^e   Lundbäck, Bo ^e,f   Djukanović, Ratko ^d   Holgate, Stephen ^d   Wilson, Susan ^d,g  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Department of Lung Medicine ^*  (Norway)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e Boden Hospital   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchoscopy; Fluticasone propionate; Inflammation; Randomized controlled trial; Salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LONG ACTING DRUG; SALMETEROL;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHITIS; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LOW DRUG DOSE; LUNG LAVAGE; MALE; MAST CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBMUCOSA; TRACHEOBRONCHIAL TOILET; TREATMENT OUTCOME;

EID: 0038681170     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1518     Document Type: Article

References (25)

1. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
2. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
3. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, et al. Prednisolone treatment in asthma: reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;153:551-6.
4. Ädelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9.
5. Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop report. Bethesda (MD): National Institutes of Health; 1995. Publication 95-3659.
6. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-71.
7. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. Am J Respir Crit Care Med 2000;161:224-31.
8. Faul JL, Leonard CT, Burke CM, Tormey VJ, Poulter LW. Fluticasone propionate induced alterations to lung function and immunopathology of asthma over time. Thorax 1998;53:753-61.
9. Brutsche MH, Brutsche IC, Munavvar M, Langley SJ, Masterson CM, Daley-Yates P, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000;356:556-61.
10. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998;157:S8.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid: Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-24.
12. Woolcock A, Lundbäck B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
13. van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999;54:207-14.
14. Vermetten FA, Boermans AJ, Luiten WD, Mulder PG, Vermue NA. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids. J Asthma 1999;36:97-106.
15. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma: Salmeterol Study Group. Ann Allergy Asthma Immunol 1999;82:383-9.
16. Li X, Ward C, Thien F, Bish R, Bamford T, Bao X, et al. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999;160:1493-9.
17. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000;320:1368-73.
18. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group (published erratum appears in N Engl J Med 1998;338:139). N Engl J Med 1997;337:1405-11.
19. Wallin A, Sandström T, Söderberg M, Howarth PH, Lundbäck B, Della-Cioppa G, et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999;159:79-86.
20. Roth M, Johnson PRA, Rudiger JJ, King GG, Ge Q, Burgess JK, et al. Interaction between glucocorticoids and β2 agonists on bronchial airway smooth muscle through synchronised cellular signalling. Lancet 2002;360:1293-9.
21. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-10.
22. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991;88:808-14.
23. Jarjour NN, Peters SP, Djukanovic R, Calhoun WJ. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998;1573:692-7.
24. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993;68:271-80.
25. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Pub Health 1996;86:726-8.